Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04528836
Title First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Navire Pharma Inc.
Indications

Advanced Solid Tumor

Therapies

IACS-13909

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST